<prompt> Please answer with one of the option in the bracket. Write reasoning in between . Write answer in between .Q:A 65-year-old man with a history of diabetes, hypertension, hyperlipidemia, and obesity is transferred from the cardiac catheterization lab to the cardiac critical care unit after sustaining a massive myocardial infarction. He received a bare metal stent and has now stabilized. However, shortly after being transferred, he reports palpitations. EKG reveals ventricular tachycardia. Your attending wishes to start an anti-arrhythmic drug with a high selectivity for ischemic cardiac myocytes. You call the nurse and ask her to begin intravenous:? A: Quinidine, B: Lidocaine, C: Dofetilide, D: Procainamide, E: Flecainide,  <response>: This is a clinical scenario about a 65-year-old man with multiple comorbidities who developed ventricular tachycardia after receiving a bare metal stent for a myocardial infarction. The question asks which antiarrhythmic drug that is highly selective for ischemic cardiac myocytes should be started intravenously. Quinidine, dofetilide, and flecainide are all Class I antiarrhythmics that can be used for ventricular tachycardia, but they are not ideal options in this setting. Lidocaine is a Class Ib antiarrhythmic that is the first-line treatment for ventricular tachycardia in the setting of acute myocardial infarction. It has high selectivity for ischemic tissues.Procainamide is also a Class Ia antiarrhythmic that is highly selective for ischemic cardiac myocytes. It can be used intravenously in ventricular arrhythmias.Based on the patients presentation and the attendings wish for a drug selective for ischemic cardiac myocytes, lidocaine and procainamide are the best options. Lidocaine may be slightly preferred as the first-line treatment.B: Lidocaine 